Method for catalytically preparing benzodiazepine compound by using titanocene dichloride
A titanocene dichloride catalysis, benzodiazepine technology, applied in chemical instruments and methods, chemical/physical processes, physical/chemical process catalysts, etc., to achieve the effects of simple operation, non-toxic solvent, and low dosage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0016] Preparation of 2,4-diphenyl-3-H-1,5-benzodiazepine with the following structural formula
[0017]
[0018] Add 0.0025g (0.01mmol) titanocene dichloride, 0.0033g (0.02mmol) isophthalic acid, 0.065g (0.6mmol) o-phenylenediamine, 0.103g (0.5mmol) 1,4-diamine to the reaction flask Phenyl-3-butyn-2-one, 1mL ethanol, stirring reaction at room temperature for 5 hours, stop the reaction, remove ethanol by rotary evaporation, separate with silica gel column (elution machine is petroleum ether and ethyl acetate volume ratio is 10: 1) to obtain 2,4-diphenyl-3-H-1,5-benzodiazepine, the yield is 96%, and the spectral data of the product is: 1 H NMR (600MHz, CDCl 3 )δ7.95-7.81(m,4H),7.53(dd,J=6.1,3.5Hz,2H),7.387.31(m,6H),7.27(dd,J=6.1,3.5Hz,2H),7.18 (s,0H),1.53(s,1H); 13 C NMR (101MHz, CDCl 3 )δ154.26, 140.83, 137.34, 130.69, 128.83, 128.77, 128.22, 125.54, 35.01.
Embodiment 2
[0024] Preparation of 2-(4-fluorophenyl)-4-phenyl-3-H-1,5-benzodiazepine with the following structural formula
[0025]
[0026] In this example, the 1,4-diphenyl-3-butane used in Example 1 was replaced with equimolar 1-(4-fluorophenyl)-4-phenyl-3-butyn-2-one Alkyn-2-one, other steps are the same as in Example 1, to obtain 2-(4-fluorophenyl)-4-phenyl-3-H-1,5-benzodiazepine, the yield is 98%, The spectral data of the product are: 1 H NMR (400MHz, CDCl 3 )δ7.97(ddd, J=7.7,4.9,2.0Hz,4H),7.62(dtd,J=7.5,3.5,1.8Hz,2H),7.43(dd,J=5.2,2.0Hz,3H),7.35 (dd,J=6.2,3.5Hz,2H),7.09(t,J=8.6Hz,2H); 13 C NMR (101MHz, CDCl 3 )δ 165.55, 163.05, 153.95, 152.78, 140.72, 140.59, 137.22, 133.58, 133.55, 130.74, 130.37, 130.28, 128.79, 128.72, 128.18, 128.14, 125.594, 115.8
Embodiment 3
[0028] Preparation of 2-(4-chlorophenyl)-4-phenyl-3-H-1,5-benzodiazepine with the following structural formula
[0029]
[0030] In this example, the 1,4-diphenyl-3-butane used in Example 1 was replaced with equimolar 1-(4-chlorophenyl)-4-phenyl-3-butyn-2-one Alkyn-2-one, other steps are the same as in Example 1, to obtain 2-(4-chlorophenyl)-4-phenyl-3-H-1,5-benzodiazepine, the yield is 98%, The spectral data of the product are: 1 H NMR (400MHz, CDCl 3 )δ7.96(dd, J=7.5,2.3Hz,2H),7.91(d,J=8.6Hz,2H),7.65-7.57(m,2H),7.46-7.41(m,3H),7.39(s ,1H),7.38-7.32(m,3H); 13 C NMR (101MHz, CDCl 3 )δ153.90, 152.68, 140.76, 140.47, 137.15, 136.91, 135.70, 130.78, 129.45, 128.95, 128.80, 128.73, 128.16, 125.69, 125.58, 34.82.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com